Latest News

Annual ob.gyn. visit a ‘powerful opportunity’ to talk heart health


 

FROM CIRCULATION


“Pregnancy is essentially a ‘stress test’ for women, and these adverse pregnancy outcomes can be used to identify women who are at an increased risk for ASCVD, even in those for whom the conditions resolve after delivery,” the authors said.

To reduce or prevent these issues, the authors recommended ob.gyn. clinicians perform a “thorough family history, screening for and targeted review of cardiovascular risk factors (including those unique to women), and lifestyle counseling to improve cardiovascular risk factors with the goal of preventing future cardiovascular events.”

“The American College of Cardiology/American Heart Association guidelines for the assessment of cardiovascular risk find it reasonable to screen adults free of cardiovascular disease for risk factors such as smoking, hypertension, diabetes mellitus, total cholesterol, and high-density lipoprotein cholesterol every 4-6 years between the ages of 20 and 79 years to calculate their 10-year cardiovascular risk,” they wrote.

Regarding diabetes care, clinicians should screen for abnormal glucose levels in overweight or obese patients aged between 40 and 70 years and schedule lifestyle counseling for any patients with prediabetes (HbA1c = 5.7%-6.4%), diabetes mellitus (HbA1c greater than 6.4%), gestational diabetes, or metabolic syndrome.

Recommended Reading

Nitrofurantoin beats fosfomycin for uncomplicated UTI
MDedge ObGyn
How does oral contraceptive use affect one’s risk of ovarian, endometrial, breast, and colorectal cancers?
MDedge ObGyn
2018 Update on cervical disease
MDedge ObGyn
MDedge Daily News: How smartphones could battle oral cancer
MDedge ObGyn
Time to scrap LMWH for prevention of placenta-mediated pregnancy complications?
MDedge ObGyn
Women’s representation in CV drug trials still lagging
MDedge ObGyn
VIDEO: Office-based hereditary cancer risk testing is doable
MDedge ObGyn
Universal BRCA testing worthwhile for relatives of high-grade serous ovarian cancer patients
MDedge ObGyn
Phase 2 ‘universal flu vaccine’ trial announced
MDedge ObGyn
Cochrane report: HPV vaccine proves its worth in adolescent, young adult women
MDedge ObGyn